Purchase Order 75N92023P00016
Award Date 11/21/22
Potential Completion Date 11/20/25
Potential Value $225K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a purchase order valued at $24,924.63 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD), a component of the National Institutes of Health. The contract, awarded on December 30, 2025, covers a period of performance from December 29, 2025, through July 16, 2026, with an ultimate completion date of July 17, 2026. The award encompasses service contracts for...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, received a $22,500 firm fixed-price contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) on December 19, 2019. This contract call was issued under a Blanket Purchase Agreement (BPA) with an ultimate completion date of December 31, 2019, and was awarded without a small business set-aside designation. The work is to be performed in Bethesda, Maryland, where...
- Becton, Dickinson and Company (BD), through its BD Biosciences division, was awarded a delivery order valued at $11,385.00 on October 1, 2006, for a five-day service facscan (fluorescence-activated cell sorter) maintenance and support contract. The contract was executed without a small business set-aside designation and is scheduled for ultimate completion by September 30, 2007. The service will be performed at the National Institutes of Health Clinical Center facility in Bethesda, Maryland....
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a delivery order maintenance contract (S/N B0132) valued at $10,833.96 for a one-year period from December 1, 2005, through November 30, 2006. This contract, awarded without set-aside designation, represents a renewal of a prior agreement (263FQ502734) and includes comprehensive maintenance services for a flow cytometry instrument located at the National Institutes of Health facility in Bethesda,...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a $11,955.60 firm fixed price maintenance contract by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) on June 15, 2024, with an ultimate completion date of December 14, 2024. The contract, issued as a Blanket Purchase Agreement (BPA) call, covers maintenance services for FACSCELESTA equipment at the performance location in Bethesda, Maryland. No small...
- BD Biosciences, a division of Becton, Dickinson and Company, has been awarded a firm fixed price purchase order valued at eleven thousand nine hundred fifty-two dollars and four cents ($11,952.04) by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for service of BD flow cytometers and lasers to support the agency's biomedical research programs. Performance will take place in San Jose, California through February 2024. No set-aside...
- This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $125,877.00. The contract is for an annual service agreement to maintain BD's FACS (fluorescence-activated cell sorting) flow machines and accessories used to support biomedical research and clinical applications at NIAID. The contract does not have a set-aside designation. BD is...
- BD Biosciences has been awarded a firm fixed price purchase order totaling $73,666.80 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract has no set-aside designation. BD Biosciences will provide various flow cytometers, lasers, and associated equipment in support of biomedical research being conducted by the agency. Specifically, the contract calls for BD BIOSCIENCES SYMPHONY S6 flow cytometers, FACSTATION cell sorters, and various lasers...
- Becton, Dickinson and Company (BD Biosciences division) has been awarded a firm fixed price purchase order totaling $17,668.80 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for annual service of BD Biosciences' FACSCelesta flow cytometry system located in San Jose, California, with performance through March 1, 2025. No set-aside designation was used for this procurement. BD Biosciences will provide maintenance and support for the...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $33,675.60. The contract is for BD Biosciences, a division of BD, to provide biomedical instruments, reagents, and services that support flow cytometry, cell imaging, and genomics technologies. BD has extensive experience providing specialized equipment and consumables to support...